By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Product revenue, net59K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States59K100.00%
US Stock MarketDetailed Quotes
Avalo Therapeutics (AVTX)
- 19.850
- -0.090-0.45%
Close May 13 16:00 ET
- 20.050
- +0.200+1.01%
Post 16:18 ET
1.04BMarket Cap-3.40P/E (TTM)
20.210High19.390Low1.56MVolume20.210Open19.940Prev Close30.72MTurnover3.17%Turnover RatioLossP/E (Static)52.23MShares24.27052wk High12.48P/B975.56MFloat Cap3.43152wk Low--Dividend TTM49.15MShs Float22031.712Historical High--Div Yield TTM4.11%Range %3.390Historical Low19.740Avg Price1Lot Size
Avalo Therapeutics (AVTX) Revenue Breakdown Overview
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm